# Five Years of Menopause Hormones Linked to Less Bowel Cancer

_Evidence Level: Preliminary · Siitonen H et al., Maturitas, DOI 10.1016/j.maturitas.2026.109188_

*Risk of colorectal cancer and systemic menopausal hormone therapies: a Finnish cohort study.*

- **Evidence Level**: Preliminary
- **Why this grade**: Register data on about 730,000 women over 18 years on average, but analysed looking back; other differences between the women may shape the result.
- **Facts**: Design: Retrospective cohort study · Duration: 18 years · Funding: Abbott Fund; Finnish Ministry of Social Affairs and Health; Finnish Academy of…
- **Publication Types**: Journal Article
- **Journal**: Maturitas
- **Sample Size**: 728,608 women in Finland
- **Authors**: Siitonen H, Joensuu JM, Savolainen-Peltonen H, Ylikorkala O, Mikkola TS
- **Graded and published**: 2026-11-07
- **Last edited**: 2026-11-11
- **Topics**: Women's Health, Hormones
- **DOI**: https://doi.org/10.1016/j.maturitas.2026.109188
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/43008428/

## Summary

Finnish women who used hormone therapy for menopause for at least five years were slightly less likely to develop bowel cancer. Their risk of cancer in the colon or rectum was 12 percent lower than in women of the same age who did not use hormone therapy. This difference lasted for more than five years after they stopped.

The researchers drew on national registers. They compared 364,304 women who used menopausal hormone therapy with the same number of women of the same age who did not. On average, the data covered 18 years. Few women in either group got the disease, a little over 1 in 100.

The type of hormone stood out. With estrogen alone, the risk was 19 percent lower. With estrogen combined with a progestogen, a hormone similar to the body's own progesterone, it was 8 percent lower. The researchers therefore suspect that estrogen mainly drives the difference. For cancer of the rectum, a lower risk showed up only after ten or more years of use. The study is based on register data. It cannot say for sure whether the hormones themselves protect or whether the women differed in other ways.

## Practical Takeaway

Finnish women who took menopausal hormones for five years or longer developed bowel cancer slightly less often.

---

_Canonical: https://longevity-cities.com/en/research/five-years-of-menopause-hormones-linked-to-less-bowel-cancer · Part of Longevity Cities · Updated 2026-11-11_
